Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/19/2025

Antiviral Treatment Guidelines

Introduction to Herpes Zoster

  • Herpes zoster typically presents with a unilateral vesicular eruption in a dermatomal distribution, prodromal pain, and progression from erythematous macules to papules, vesicles, pustules, and finally crusting, with lesions typically continuing to erupt for 4-6 days in immunocompetent hosts and a complete disease duration of approximately 2 weeks in healthy individuals 1, 2, 3, 4
  • Diagnosis is typically made based on clinical presentation and prodromal symptoms, and confirmed by direct testing of lesion material, such as PCR testing of vesicle fluid, direct fluorescent antibody testing, and viral culture from blister material, with sensitivity and specificity approaching 100% 1, 4

Treatment Regimens

  • The Centers for Disease Control and Prevention recommends intravenous acyclovir at a dose of 10 mg/kg every 8 hours for 7-10 days for patients with severe disease 5
  • Antiviral therapy options include valacyclovir 1000 mg three times daily for 7 days, famciclovir 500 mg three times daily for 7 days, or acyclovir 800 mg five times daily for 7 days, as recommended by the IDSA 2, 3, 6
  • The American College of Physicians recommends ensuring a complete 7-day course of antivirals for immunocompetent patients, with longer duration for immunocompromised patients 2
  • Immunocompromised patients, including those with HIV, cancer, or transplant recipients, and those on immunosuppressive medications, are at higher risk for complications and may require extended treatment duration for herpes zoster infection 7, 1, 8, 9, 10, 2, 11

Pain Management

  • The American College of Physicians recommends gabapentin as the first-line oral pharmacological treatment for severe shingles pain, titrated to 2400 mg per day in divided doses, starting with 300 mg once daily and gradually increasing 6
  • The IDSA suggests adding pregabalin for patients with post-herpetic neuralgia 6
  • The American Academy of Neurology recommends considering tricyclic antidepressants (nortriptyline or desipramine) starting at low doses and titrating up to 50-75 mg, and hypnosis for neuropathic pain (strong recommendation) 6
  • Capsaicin 8% patch can be applied as a single 30-minute application at the site of pain, providing pain relief for up to 12 weeks, and pre-treatment with 4% lidocaine for 60 minutes can manage application-related discomfort 6

Ocular Involvement

  • The American Academy of Ophthalmology recommends topical corticosteroids at the minimum effective dose for symptoms such as blurring, photophobia, and decreased vision, with slow tapering to minimize side effects 12
  • Topical antivirals may be used as adjunctive treatment in unresponsive cases, though not effective as monotherapy, according to the American Academy of Ophthalmology 13
  • Evaluation for conjunctivitis, keratitis, pseudodendrites, corneal scarring, uveitis/iritis, sectoral iris atrophy, and secondary glaucoma is required for patients with ocular involvement, as recommended by the American Academy of Ophthalmology 13

Prevention and Vaccination

  • The Centers for Disease Control and Prevention recommend recombinant zoster vaccine for adults aged 50 years and older to prevent future outbreaks and complications, with the recombinant zoster vaccine (RZV) available for adults 50 years and older, as recommended by the Advisory Committee on Immunization Practices 13, 14
  • Vaccination is the most effective strategy to prevent herpes zoster and its complications, as stated by the National Foundation for Infectious Diseases 14
  • Household contacts (especially children) of susceptible immunocompromised persons should be vaccinated against VZV if they have no history of chickenpox and are seronegative for HIV, as recommended by the CDC 8, 15, 16

Follow-up and Monitoring

  • Regular follow-up examinations should include interval history, visual acuity measurement, intraocular pressure measurement, and slit-lamp biomicroscopy, as recommended by the American Academy of Ophthalmology 12
  • More vigilant monitoring for disseminated disease is recommended, particularly in high-risk populations 5
  • Patients with low immune cell counts, such as CD4 counts <200 cells/ml, should be offered antiviral prophylaxis with acyclovir or valacyclovir to prevent herpes zoster infection 7

REFERENCES

14